UPDATE: SVB Leerink Assumes Regeneron Pharma (REGN) at Outperform
Tweet Send to a Friend
(Updated - May 23, 2022 3:46 AM EDT)
SVB Leerink analyst Andrew Berens assumes coverage on Regeneron Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
SVB Leerink analyst Andrew Berens assumes coverage on Regeneron Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
